These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats. Ferron GM; Pyszczynski NA; Jusko WJ J Pharmacokinet Biopharm; 1999 Feb; 27(1):1-21. PubMed ID: 10533695 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits. Ferron GM; Jusko WJ Pharm Res; 1998 Dec; 15(12):1888-94. PubMed ID: 9892474 [TBL] [Abstract][Full Text] [Related]
5. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566 [TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus. Combates NJ; Degiannis D; Raskova J; Raska K Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077 [TBL] [Abstract][Full Text] [Related]
9. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin. Hornung N; Raskova J; Raska K; Degiannis D Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641 [TBL] [Abstract][Full Text] [Related]
10. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood. Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903 [TBL] [Abstract][Full Text] [Related]
11. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats. Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin's inhibition of thymocyte proliferation, unlike that of cyclosporin A or prednisolone, is not associated with cytotoxicity. Bansbach CC; Wancio D; Caccese RG; Shen CF; Sehgal SN Ann N Y Acad Sci; 1993 Jun; 685():114-6. PubMed ID: 8363214 [No Abstract] [Full Text] [Related]
13. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation. Hess DA; Bird IA; Almawi WY; Rieder MJ J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542 [TBL] [Abstract][Full Text] [Related]
14. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection. Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913 [TBL] [Abstract][Full Text] [Related]
15. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro. Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. Akselband Y; Harding MW; Nelson PA Transplant Proc; 1991 Dec; 23(6):2833-6. PubMed ID: 1721292 [No Abstract] [Full Text] [Related]
18. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes. Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382 [No Abstract] [Full Text] [Related]
19. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells. Kim HS; Raskova J; Degiannis D; Raska K Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821 [TBL] [Abstract][Full Text] [Related]
20. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine. Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]